BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2012
View Archived Issues
Preclinical and first clinical data disclosed on MLN-2480
Read More
Bayer Healthcare presents new oral selective PI3K inhibitor
Read More
Research at Astellas yields novel phosphodiesterase 9A inhibitors
Read More
UCB describes new PI3K inhibitors
Read More
Novel histone deacetylase inhibitors patented by Roche
Read More
IRM discloses new Trk inhibitors
Read More
Novel potential malaria therapies discovered
Read More
New HCV NS3/NS4A inhibitor characterized
Read More
Takeda reports on efforts to develop new HER2/EGFR kinase inhibitors
Read More
Mutant caveolin-1-derived peptide reduces atherosclerotic lesions
Read More
Novel ApoA-I-mimetic peptide shows promise as atherosclerosis drug
Read More
Affymax receives new milestone payment from Takeda for Omontys
Read More
AmiKet receives FDA fast track status
Read More
Phase II AKB-6548 study meets primary endpoint
Read More
Omeros begins enrollment in second phase III OMS-302 trial
Read More
Marshall Edwards clear to move lead mitochondrial inhibitor to clinic
Read More
PharmaMar to halt Irvalec development in gastroesophageal tumors
Read More
KineMed receives NIH grant to support development of ApoA-I HDL mimetic
Read More
Korlym now available in U.S.
Read More
Targacept reports revised topline data from phase II TC-6987 study
Read More
AnaptysBio enters strategic antibody discovery partnership
Read More
Sucampo reports topline phase III lubiprostone data
Read More
HSP 90 inhibitor enters phase I trial in multiple myeloma
Read More
Stealth Peptides reports on phase I Bendavia studies
Read More
Biovest to file marketing application in Canada
Read More
Amgen announces new acquisition agreement
Read More